Genetic diseases with pigmentary manifestations (eg, oculocutaneous albinism, piebaldism, Waardenburg syndrome, tuberous sclerosis, neurofibromatosis) are reviewed in Chapter 360
[2] [9] By activating GLP-1 receptors, retatrutide is thought to enhance insulin secretion in a glucose-dependent manner, suppress glucagon release, and reduce appetite
If vomiting persists or becomes severe, consult with your practitioner about adjusting your treatment plan
Particularly in those who are genetically predisposed, external and environmental variables play a significant role in the start and progression of IBD, a complicated multifactorial illness
doi: 10.1002/edm2.v7.1 11 PerkovicVTuttleKRRossingPMahaffeyKWMannJFEBakrisGet al